Vascular access complications after catheter ablation of ventricular arrhythmias: Impact of vascular closure devices.

IF 8.3 2区 材料科学 Q1 MATERIALS SCIENCE, MULTIDISCIPLINARY ACS Applied Materials & Interfaces Pub Date : 2024-09-06 DOI:10.1016/j.hrthm.2024.09.001
Chadi Tabaja, Nolan Hight, Arwa Younis, Shada Jadam, Joe Demian, Ayman Hussein, Jakub Sroubek, Walid Saliba, Mohamed Kanj, Mandeep Bhargava, Bryan Baranowski, Thomas Callahan, Mina Chung, Thomas Dresing, Justin Lee, Koji Higuchi, Ioan Liuba, David Martin, Shady Nakhla, John Rickard, Niraj Varma, Tyler Taigen, Oussama Wazni, Pasquale Santangeli
{"title":"Vascular access complications after catheter ablation of ventricular arrhythmias: Impact of vascular closure devices.","authors":"Chadi Tabaja, Nolan Hight, Arwa Younis, Shada Jadam, Joe Demian, Ayman Hussein, Jakub Sroubek, Walid Saliba, Mohamed Kanj, Mandeep Bhargava, Bryan Baranowski, Thomas Callahan, Mina Chung, Thomas Dresing, Justin Lee, Koji Higuchi, Ioan Liuba, David Martin, Shady Nakhla, John Rickard, Niraj Varma, Tyler Taigen, Oussama Wazni, Pasquale Santangeli","doi":"10.1016/j.hrthm.2024.09.001","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Vascular access site complications are the most frequent complications of percutaneous catheter ablation (CA) of ventricular arrhythmias (VAs). Whether arterial/venous vascular closure devices (VCDs) prevent vascular complications is unknown.</p><p><strong>Objective: </strong>We investigated the benefit of VCDs in patients undergoing CA of VAs.</p><p><strong>Methods: </strong>Consecutive CA of VAs were included (2018-2022). Vascular accesses were obtained with ultrasound guidance. At the discretion of the operator, arterial and/or venous VCDs were used. Cases were divided into 3 groups: no use of VCDs for any arterial/venous accesses (manual compression [MC]), use of VCDs for some but not all accesses (Partial-VCDs), and use of VCDs for all accesses (Complete-VCDs). Vascular complications were classified as minor if they did not require intervention or major if they required intervention.</p><p><strong>Results: </strong>A total of 1016 procedures were performed in 872 patients (mean age 62 ± 13 years; mean body mass index 30 ± 6 kg/m<sup>2</sup>; 27% female) during the study period. Femoral arterial access was obtained in 887 procedures (875 single access: 7.4 ± 1.5 F size; 12 two accesses: 7.3 ± 3 and 6.9 ± 1.8 F). Femoral venous access was obtained in 1014 procedures (unilateral in 17%; bilateral in 83%; mean number of access sites per patient 2.6 ± 0.7; mean size 8.4 ± 1.3 F). Hemostasis was achieved with MC in 192 procedures (19%), with Partial-VCD in 275 (27%), and with Complete-VCD in 549 (54%). A vascular complication occurred in 52 procedures (5.1%), including a minor hematoma in 3.9% and/or a major complication in 1.7%. The rate of vascular complications was 6.8% (5.2% minor and 1.6% major) in the MC group, 7.6% (5.1% minor and 3.3% major) in the Partial-VCD group, and 3.3% (2.9% minor and 0.9% major) in the Complete-VCD group (P = .014 for comparison). In multivariable analysis, Complete-VCD remained independently associated with a lower risk of vascular complications (odds ratio 0.69; 95% confidence interval 0.48-0.96; P = .036).</p><p><strong>Conclusion: </strong>In patients undergoing CA of VAs, Complete-VCD is associated with lower rates of vascular-related complications compared with MC or Partial-VCD.</p>","PeriodicalId":5,"journal":{"name":"ACS Applied Materials & Interfaces","volume":null,"pages":null},"PeriodicalIF":8.3000,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Materials & Interfaces","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.hrthm.2024.09.001","RegionNum":2,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MATERIALS SCIENCE, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Vascular access site complications are the most frequent complications of percutaneous catheter ablation (CA) of ventricular arrhythmias (VAs). Whether arterial/venous vascular closure devices (VCDs) prevent vascular complications is unknown.

Objective: We investigated the benefit of VCDs in patients undergoing CA of VAs.

Methods: Consecutive CA of VAs were included (2018-2022). Vascular accesses were obtained with ultrasound guidance. At the discretion of the operator, arterial and/or venous VCDs were used. Cases were divided into 3 groups: no use of VCDs for any arterial/venous accesses (manual compression [MC]), use of VCDs for some but not all accesses (Partial-VCDs), and use of VCDs for all accesses (Complete-VCDs). Vascular complications were classified as minor if they did not require intervention or major if they required intervention.

Results: A total of 1016 procedures were performed in 872 patients (mean age 62 ± 13 years; mean body mass index 30 ± 6 kg/m2; 27% female) during the study period. Femoral arterial access was obtained in 887 procedures (875 single access: 7.4 ± 1.5 F size; 12 two accesses: 7.3 ± 3 and 6.9 ± 1.8 F). Femoral venous access was obtained in 1014 procedures (unilateral in 17%; bilateral in 83%; mean number of access sites per patient 2.6 ± 0.7; mean size 8.4 ± 1.3 F). Hemostasis was achieved with MC in 192 procedures (19%), with Partial-VCD in 275 (27%), and with Complete-VCD in 549 (54%). A vascular complication occurred in 52 procedures (5.1%), including a minor hematoma in 3.9% and/or a major complication in 1.7%. The rate of vascular complications was 6.8% (5.2% minor and 1.6% major) in the MC group, 7.6% (5.1% minor and 3.3% major) in the Partial-VCD group, and 3.3% (2.9% minor and 0.9% major) in the Complete-VCD group (P = .014 for comparison). In multivariable analysis, Complete-VCD remained independently associated with a lower risk of vascular complications (odds ratio 0.69; 95% confidence interval 0.48-0.96; P = .036).

Conclusion: In patients undergoing CA of VAs, Complete-VCD is associated with lower rates of vascular-related complications compared with MC or Partial-VCD.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
室性心律失常导管消融术后的血管通路并发症:血管闭合装置的影响。
背景:血管通路部位并发症是室性心律失常(VAs)经皮导管消融术(CA)最常见的并发症。动脉/静脉血管封闭装置(VCD)能否预防血管并发症尚不清楚:我们研究了 VCD 对接受室性心律失常 CA 患者的益处:纳入了VAs的连续CA(2018-2022年)。在超声引导下获得血管通路。根据操作者的判断,使用动脉和/或静脉 VCD。病例分为 3 组:任何动/静脉通路均未使用 VCD(手动加压 - MC)、部分但非全部通路使用 VCD(部分-VCD)、全部通路使用 VCD(完全-VCD)。血管并发症如果不需要干预,则定义为轻微并发症;如果需要干预,则定义为严重并发症:研究期间共为 872 名患者(62±13 岁,体重指数 30±6kg/m2,27% 为女性)实施了 1,016 例手术。887例手术获得了股动脉通路(875例单条通路--7.4±1.5 Fr,12例两条通路--7.3±3 Fr和6.9±1.8 Fr)。1,014例手术获得了股静脉通路(17%为单侧,83%为双侧,平均N.2.6±0.7,8.4±1.3 Fr)。192例(19%)手术通过MC止血,275例(27%)通过部分VCD止血,549例(54%)通过完全VCD止血。52例(5.1%)手术发生了血管并发症,其中3.9%为轻微血肿,1.7%为严重并发症。MC组的血管并发症发生率为6.8%(5.2%为轻微并发症,1.6%为严重并发症),部分VCD组为7.6%(5.1%为轻微并发症,3.3%为严重并发症),完全VCD组为3.3%(2.9%为轻微并发症,0.9%为严重并发症,对比P=0.014)。在多变量分析中,完全VCD仍与较低的血管并发症风险独立相关(几率比0.69,95%置信区间0.48至0.96,P=0.036):结论:与MC或部分VCD相比,在接受VAs CA手术的患者中,完全VCD与较低的血管相关并发症发生率有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
ACS Applied Materials & Interfaces
ACS Applied Materials & Interfaces 工程技术-材料科学:综合
CiteScore
16.00
自引率
6.30%
发文量
4978
审稿时长
1.8 months
期刊介绍: ACS Applied Materials & Interfaces is a leading interdisciplinary journal that brings together chemists, engineers, physicists, and biologists to explore the development and utilization of newly-discovered materials and interfacial processes for specific applications. Our journal has experienced remarkable growth since its establishment in 2009, both in terms of the number of articles published and the impact of the research showcased. We are proud to foster a truly global community, with the majority of published articles originating from outside the United States, reflecting the rapid growth of applied research worldwide.
期刊最新文献
Decreased levels of phosphorylated synuclein in plasma are correlated with poststroke cognitive impairment. Small molecule inhibitor DDQ-treated hippocampal neuronal cells show improved neurite outgrowth and synaptic branching. Polyethylene glycol fusion repair of severed sciatic nerves accelerates recovery of nociceptive sensory perceptions in male and female rats of different strains. Reduced mesencephalic astrocyte-derived neurotrophic factor expression by mutant androgen receptor contributes to neurodegeneration in a model of spinal and bulbar muscular atrophy pathology. Enhanced autophagic clearance of amyloid-β via histone deacetylase 6-mediated V-ATPase assembly and lysosomal acidification protects against Alzheimer's disease in vitro and in vivo.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1